Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model

Bone

Volumn 41, Issue 5, 2007, Pages 775-785

  Abe, Yuichiro ^a   Takahata, Masahiko ^a   Ito, Manabu ^a   Irie, Kazuharu ^b   Abumi, Kuniyoshi ^a   Minami, Akio ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Bone graft; Bone remodeling; Microstructural indices analysis; Parathyroid hormone; Spinal arthrodesis surgery

Indexed keywords

MESSENGER RNA; PARATHYROID HORMONE[1-34]; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRODESIS; ARTICLE; BONE GRAFT; BONE METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG INHIBITION; FRACTURE HEALING; GENE CONTROL; HISTOPATHOLOGY; LUMBAR SPINE; MALE; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINE FUSION; SPINE SURGERY; THREE DIMENSIONAL IMAGING;

ANIMALS; ARTHRODESIS; BASE SEQUENCE; BONE TRANSPLANTATION; DNA PRIMERS; GENE EXPRESSION PROFILING; GRAFT SURVIVAL; HUMANS; MALE; MODELS, ANIMAL; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPINE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35348903858     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.06.025     Document Type: Article

References (47)

1. Alkhiary Y.M., Gerstenfeld L.C., Krall E., Westmore M., Sato M., Mitlak B.H., et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 87 (2005) 731-741
2. Andreassen T.T., Ejersted C., and Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14 (1999) 960-968
3. Andreassen T.T., Willick G.E., Morley P., and Whitfield J.F. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif Tissue Int 74 (2004) 351-356
4. Black D.M., Bilezikian J.P., Ensrud K.E., Greenspan S.L., Palermo L., Hue T., et al. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med 353 (2005) 555-565
5. Boden S.D. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 27 (2002) S26-S31
6. Boden S.D., Schimandle J.H., and Hutton W.C. An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine 20 (1995) 412-420
7. Boden S.D., Titus L., Hair G., Liu Y., Viggeswarapu M., Nanes M., et al. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 23 (1998) 2486-2492
8. Bridwell K.H., Sedgewick T.A., O'Brien M.F., Lenke L.G., and Baldus C. The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis. J Spinal Disord 6 (1993) 461-472
9. Buxton E.C., Yao W., and Lane N.E. Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). J Clin Endocrinol Metab 89 (2004) 3332-3336
10. Cosman F., Nieves J., Woelfert L., Formica C., Gordon S., Shen V., et al. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal. J Bone Miner Res 16 (2001) 925-931
11. Cypher T.J., and Grossman J.P. Biological principles of bone graft healing. J Foot Ankle Surg 35 (1996) 413-417
12. Dempster D.W., Cosman F., Kurland E.S., Zhou H., Nieves J., Woelfert L., et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16 (2001) 1846-1853
13. Dempster D.W., Cosman F., Parisien M., Shen V., and Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr Rev 14 (1993) 690-709
14. DeWald C., and Stanley J. Instrumentation-related complications of multilevel fusions for adult spinal deformity patients over age 65: surgical considerations and treatment options in patients with poor bone quality. Spine 31 (2006) S144-S151
15. Ferrari S.L., Pierroz D.D., Glatt V., Goddard D.S., Bianchi E.N., Lin F.T., et al. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. Endocrinology 146 (2005) 1854-1862
16. Finkelstein J.S., Klibanski A., Schaefer E.H., Hornstein M.D., Schiff I., and Neer R.M. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331 (1994) 1618-1623
17. Hing K.A. Bone repair in the twenty-first century: biology, chemistry or engineering?. Philos Transact A Math Phys Eng Sci 362 (2004) 2821-2850
18. Hock J.M., and Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 7 (1992) 65-72
19. Holzer G., Majeska R.J., Lundy M.W., Hartke J.R., and Einhorn T.A. Parathyroid hormone enhances fracture healing. A preliminary report. Clin Orthop Relat Res (1999) 258-263
20. Horwitz M.J., Tedesco M.B., Gundberg C., Garcia-Ocana A., and Stewart A.F. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 88 (2003) 569-575
21. Huang R.C., Khan S.N., Sandhu H.S., Metzl J.A., Cammisa F.P., Zheng F., et al. Alendronate inhibits spine fusion in a rat model. Spine 30 (2005) 2516-2522
22. Ito M., Nishida A., Koga A., Ikeda S., Shiraishi A., Uetani M., et al. Contribution of trabecular and cortical components to the mechanical properties of bone and their regulating parameters. Bone 31 (2002) 351-358
23. Kinney J.H., and Ladd A.J. The relationship between three-dimensional connectivity and the elastic properties of trabecular bone. J Bone Miner Res 13 (1998) 839-845
24. Komatsubara S., Mori S., Mashiba T., Nonaka K., Seki A., Akiyama T., et al. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 36 (2005) 678-687
25. Kon T., Cho T.J., Aizawa T., Yamazaki M., Nooh N., Graves D., et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16 (2001) 1004-1014
26. Lindsay R., Nieves J., Formica C., Henneman E., Woelfert L., Shen V., et al. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350 (1997) 550-555
27. Locklin R.M., Khosla S., Turner R.T., and Riggs B.L. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 89 (2003) 180-190
28. Ma Y.L., Cain R.L., Halladay D.L., Yang X., Zeng Q., Miles R., et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142 (2001) 4047-4054
29. McGuire R.A., and Amundson G.M. The use of primary internal fixation in spondylolisthesis. Spine 18 (1993) 1662-1672
30. Miyakoshi N., Kasukawa Y., Linkhart T.A., Baylink D.J., and Mohan S. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 142 (2001) 4349-4356
31. Mofidi A., Sedhom M., O'Shea K., Fogarty E.E., and Dowling F. Is high level of disability an indication for spinal fusion? Analysis of long-term outcome after posterior lumbar interbody fusion using carbon fiber cages. J Spinal Disord Tech 18 (2005) 479-484
32. Nakajima A., Shimoji N., Shiomi K., Shimizu S., Moriya H., Einhorn T.A., and Yamazaki M. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17 (2002) 2038-2047
33. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344 (2001) 1434-1441
34. Ondra S.L., and Marzouk S. Revision strategies for lumbar pseudarthrosis. Neurosurg Focus 15 (2003) E9
35. Qin L., Raggatt L.J., and Partridge N.C. Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol Metab 15 (2004) 60-65
36. Salamon M.L., Althausen P.L., Gupta M.C., and Laubach J. The effects of BMP-7 in a rat posterolateral intertransverse process fusion model. J Spinal Disord Tech 16 (2003) 90-95
37. Schimandle J.H., and Boden S.D. Spine update. The use of animal models to study spinal fusion. Spine 19 (1994) 1998-2006
38. Seebach C., Skripitz R., Andreassen T.T., and Aspenberg P. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 22 (2004) 472-478
39. Skripitz R., Andreassen T.T., and Aspenberg P. Strong effect of PTH (1-34) on regenerating bone: a time sequence study in rats. Acta Orthop Scand 71 (2000) 619-624
40. Ulrich D., van Rietbergen B., Laib A., and Ruegsegger P. The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25 (1999) 5-60
41. Vaccaro A.R., Chiba K., Heller J.G., Patel T., Thalgott J.S., Truumees E., et al. Bone grafting alternatives in spinal surgery. Spine J 2 (2002) 206-215
42. Vahle J.L., Sato M., Long G.G., Young J.K., Francis P.C., Engelhardt J.A., et al. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol 30 (2002) 312-321
43. West III J.L., Bradford D.S., and Ogilvie J.W. Results of spinal arthrodesis with pedicle screw-plate fixation. J Bone Joint Surg Am 73 (1991) 1179-1184
44. Whitecloud III T.S., Davis J.M., and Olive P.M. Operative treatment of the degenerated segment adjacent to a lumbar fusion. Spine 19 (1994) 531-536
45. Yamaguchi M., Ogata N., Shinoda Y., Akune T., Kamekura S., Terauchi Y., et al. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice. Endocrinology 146 (2005) 2620-2628
46. Zdeblick T.A. A prospective, randomized study of lumbar fusion. Preliminary results. Spine 18 (1993) 983-991
47. Zipfel G.J., Guiot B.H., and Fessler R.G. Bone grafting. Neurosurg Focus 14 (2003) e8